- Fee assured
- Verified this account
Dr Ananth Nayak joined the team at University Hospital of North Midlands NHS Trust in 2013 as Consultant Physician in Endocrinology, Diabetes and General Medicine, having undertaken the higher specialist-training programme as Specialist Registrar, including over 2 years of Clinical Research Fellowship in the West Midlands region. He obtained CCT and post-nominal MRCP (endocrinology and diabetes) during his training.
Soon after joining the Trust Dr Nayak led by example in developing innovative ways of running the joint antenatal diabetes clinics; improving efficiency and patient satisfaction. Dr Nayak is an ARSAC certified endocrine consultant and has revamped the radioactive-iodine service for benign thyroid disease in the Trust. He has been instrumental in expanding the regional insulin pump services and in incorporating innovative technology in effective diabetes management.
Dr Nayak also actively collaborates with colleagues to support the diabetes renal service research and in designing novel pathways for managing endocrinopathies in conjunction with other specialties. The clinical research and service development projects undertaken by Dr Nayak have been recognised nationally and internationally with numerous peer review publications in high impact diabetes and endocrine journals. He is also involved with undergraduate medical students at Keele University and Royal College of Physicians College Tutor at UHNM supporting training for post-graduate medical trainee doctors.
Areas of interest
Diabetes Mellitus (type 1 and type 2 diabetes); Thyroid and Parathyroid disorders; Adrenal and; Pituitary disease; Metabolic disorders related to Calcium and Sodium; Antenatal Diabetes & Endocrine
Current NHS consultant posts held
Consultant Physician and RCP College Tutor; Hon Clinical Lecturer (Keele University)
Endocrinology, Diabetes and General Medicine
University Hospital of North Midlands NHS Trust
Stoke on Trent ST4 6QG
My research focus has been on exploring the impact of variance of HbA1c (a measure of intracellular glycation) from extracellular glycaemia leading to the novel concept of 'glycation gap' in diabetes.
My initial epidemiological research studies have been the first published evidence in literature, through robust methodology, confirming the consistency of the glycation gap in diabetes and its association with demographics, vascular complications and mortality in diabetes (Nayak et al Diabetes Care 2011 and 2013; Diabetes 2018).
Through my own research in Antenatal Diabetes at UHNM we have demonstrated significant reduction in key pregnancy outcomes by treating women with gestational diabetes incorporating HbA1c in screening.
My research has been presented at International and National meetings. I have been a co-investigator in the multi-centre national studies and also clinical trials at UHNM.
Music – proficient in percussion instrument Tabla; Playing Badminton & Cricket
Received the Young Diabetologist and Endocrinologist Forum Travel award in Diabetes UK APC 2015
(Selected High impact publications)
1. Exenatide therapy in insulin treated type 2 diabetes and obesity. QJM 2010; 103:687-694
2. Evidence for consistency in the glycation gap in diabetes. Diab Care 2011;34:1712-6.
3. The association of glycation gap with mortality and vascular complications in diabetes. Diabetes Care 2013;36:3247-3253
4. Hemoglobin A1c in early postpartum screening of women with gestational diabetes. World J Diabetes 2013;4:76-81.
5. Challenges of emerging adulthood-transition from paediatric to adult diabetes. World J Diabetes. 2014 Oct 15;5:630-5
6. The association between postprandial urinary C-peptide creatinine ratio and the treatment response to liraglutide: a multi-centre observational study. Diabet Med. 2014;31:403-11
7. Can a baseline morning cortisol predict outcome of short Synacthen test in an endocrine unit in an outpatient setting. Clin Endocrinol (Oxf). 2015 Feb;82:309-11
8. Too pushed to Discharge? – Hyponatraemia and its impact in hospitalised patients. Int J Endocrinol Metab Disord 2016;2(4)
9. Wide Variation in Biochemical Estimated Renal Function after Bariatric Surgery. J Endocrinol Diabetes Res. 2016;1(2)
10. Thymic hyperplasia and its spontaneous resolution with treatment of Graves' hyperthyroidism. BMJ Case Reports 2016; doi:10.1136/bcr-2016-215285
11. Course of Diabetic retinopathy following bariatric surgery in patients with Type 2 diabetes: the immediate and late impact of glycaemic control. Integr Obesity Diabetes 2017;3(6):1-5. doi: 10.15761/IOD.1000195
12. Thyrotoxicosis in patients with hypothyroidism is not just overtreatment. BMJ Case Rep. 2017 Jul 14;2017.
13. Evidence That Differences in Fructosamine-3-Kinase Activity May Be Associated With the Glycation Gap in Human Diabetes. Diabetes 2018;67(1):131-136.
Courses offered to GPs
GP INTERACTIVE FORUM:
I have undertaken educational meetings for local GPs out of hours and received excellent written feedback on my presentation skills and enhancing their skills.
I also regular present at regional GP teaching sessions.
- MBBS Gulbarga 2001
- MRCP Endocrinology Royal College of Physician of UK 2013
- FRCP Royal College of Physicians, Edinburgh 2014
- Postgrad Cert Med Edn Staffordshire University 2013
- FRCP Royal College of Physicians, London 2018
Reference number 6046165
Details of entry to specialist register
- CCT - Endocrinology & Diabetes; General Internal Medicine, 2013
Affiliations / memberships
Association of British Clinicians & Diabetologists, UK
British Thyroid Association
British Thyroid Foundation
Society for Endocrinology
British Medical Association
- Clayton RoadNEWCASTLE-UNDER-LYMEST5 4DB
- 17:30 - 20:00
- 01782 625431
- Middlewich RoadLeightonCREWECW1 4QP
- 18:00 - 20:00
- 01270 500411
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
Myself via secretary on 01782614419